23andMe is ending its cancer research program and slashing over 200 jobs - The Verge

23andMe is laying off 40 percent of its workforce ,or around 200 workers, as the company struggles to stay afloat. It’s also shuttering its therapeutics division.

By: The Verge

Nov 13 2024
0
0 Views

23andMe is ending its cancer research program and slashing over 200 jobs 23andMe is ending its cancer research program and slashing over 200 jobs / The genetic testing firm plans to license or sel… [+1511 chars]

11 bank stocks trading at low valuations, even after Trump bump - MarketWatch

Coinbase, MicroStrategy Stocks Fall. Why It's a Volatile Day for Crypto Shares. - Barron's

Hertz continues to get thrashed by EVs, updates plans for massive fire sale - TESLARATI

Netflix used to not have ads, now it’s ‘celebrating’ two years with them - The Verge

Exclusive | CEO of Saudi Arabia’s Futuristic City Project Leaves Abruptly - The Wall Street Journal

Waymo’s robotaxis are now available to everyone in Los Angeles - The Verge

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network

all our websites